Identification of a novel bluetongue virus 1 specific B cell epitope using monoclonal antibodies against the VP2 protein

被引:1
作者
Wang, Aiping [1 ]
Du, Jinran [1 ]
Feng, Hua [2 ]
Zhou, Jingming [1 ]
Chen, Yumei [1 ]
Liu, Yankai [1 ]
Jiang, Min [1 ]
Jia, Rui [1 ]
Tian, Yuanyuan [1 ]
Zhang, Gaiping [1 ]
机构
[1] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Peoples R China
[2] Henan Acad Agr Sci, Key Lab Anim Immunol, Zhengzhou 450002, Peoples R China
关键词
Bluetongue virus; VP2; protein; Monoclonal antibodies; Epitope; MODELS;
D O I
10.1016/j.ijbiomac.2021.05.053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bluetongue (BT) is a non-contact infectious disease caused by Bluetongue virus (BTV), which can be transmitted by vector insects such as Culicoides and Aedes mosquitoes. The BTV VP2 protein encoded by the L2 gene is located at the outermost layer of the virus particle, plays a key role onmediating the adsorption and entry of virus, and it is also a main antigenic protein widely used for vaccine development. In this study, the BTV1 VP2 gene was cloned into pFastBac (TM) Dual vector, and expressed in insect Sf21 cells. Immunized mice with purified recombinant VP2 protein can induce higher levels of antibodies. Three anti BTV1 VP2 monoclonal antibodies (mAbs) were generated (17E9C6, 17E9C8, 17E9H12), and showed high specific reactivity with recombinant VP2 protein and inactivated BTV1 virus. Finally, a novel linear B-cell epitope (296-)KEPAD(-300) on recombinant VP2 protein was identified by using three mAbs react with a series of continue-truncated peptides. The results of this study may provide new information on the structure and function of BTV1 VP2 protein and lay a foundation for the development of BTV1 diagnostic and prophylactic methods. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:1393 / 1401
页数:9
相关论文
共 23 条
[11]   Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes [J].
Maan, S. ;
Maan, N. S. ;
Samuel, A. R. ;
Rao, S. ;
Attoui, H. ;
Mertens, P. P. C. .
JOURNAL OF GENERAL VIROLOGY, 2007, 88 :621-630
[12]  
Maan S, 2017, VET WORLD, V10, P1464, DOI 10.14202/vetworld.2017.1464-1470
[13]   Bluetongue [J].
Maclachlan, N. J. ;
Mayo, C. E. ;
Daniels, P. W. ;
Savini, G. ;
Zientara, S. ;
Gibbs, E. P. J. .
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2015, 34 (02) :329-340
[14]   Bluetongue and epizootic hemorrhagic disease viruses: recent developments with these globally re-emerging arboviral infections of ruminants [J].
Maclachlan, Nigel James ;
Zientara, Stephan ;
Wilson, William C. ;
Richt, Juergen A. ;
Savini, Giovanni .
CURRENT OPINION IN VIROLOGY, 2019, 34 :56-62
[15]   Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion [J].
MacLachlan, NJ ;
Conley, AJ ;
Kennedy, PC .
ANIMAL REPRODUCTION SCIENCE, 2000, 60 :643-651
[16]   Ecological Dynamics Impacting Bluetongue Virus Transmission in North America [J].
Mayo, Christie ;
McDermott, Emily ;
Kopanke, Jennifer ;
Stenglein, Mark ;
Lee, Justin ;
Mathiason, Candace ;
Carpenter, Molly ;
Reed, Kirsten ;
Perkins, T. Alex .
FRONTIERS IN VETERINARY SCIENCE, 2020, 7
[17]   The combination of abundance and infection rates of Culicoides sonorensis estimates risk of subsequent bluetongue virus infection of sentinel cattle on California dairy farms [J].
Mayo, Christie E. ;
Mullens, Bradley A. ;
Gerry, Alec C. ;
Barker, Christopher M. ;
Mertens, Peter P. C. ;
Maan, Sushila ;
Maan, Narender ;
Gardner, Ian A. ;
Guthrie, Alan J. ;
MacLachlan, N. James .
VETERINARY PARASITOLOGY, 2012, 187 (1-2) :295-301
[18]  
Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]
[19]   Bluetongue Virus Capsid Assembly and Maturation [J].
Mohl, Bjorn-Patrick ;
Roy, Polly .
VIRUSES-BASEL, 2014, 6 (08) :3250-3270
[20]   Vaccines against bluetongue in Europe [J].
Savini, Giovanni ;
MacLaclalan, N. James ;
Sanchez-Vinaino, Jose-Mantiel ;
Zientara, Stephan .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2008, 31 (2-3) :101-120